Table 1

KIR ligands carried by the NK-cell donor (P61) or by different mDCs and T-cell targets

HLA class I epitope
C1*C2*HLA-Bw4 T80HLA-Bw4 I80HLA-Bw6HLA-A Bw4+*
P61 
GF 
SC 
RB 
CV 
HLA class I epitope
C1*C2*HLA-Bw4 T80HLA-Bw4 I80HLA-Bw6HLA-A Bw4+*
P61 
GF 
SC 
RB 
CV 
*

DNA of the indicated samples have been tested by sequence-specific polymorphism PCR (SSP-PCR) approach to define KIR ligands. Results obtained using set of primers that allowed to detect the presence (P) or the absence (A) of HLA-C alleles coding for C1 (HLA-C N80) or C2 (HLA-C K80) epitope, of HLA-Bw4 alleles carrying a threonine (T) or a isoleucine (I) at position 80, and of HLA-A alleles characterized by the Bw4 public epitope.

RNA of the indicated samples have been tested by SSP-PCR approach to define KIR ligands. Results obtained using set of primers that selectively amplify HLA-B alleles sharing Bw6 epitope.

Close Modal

or Create an Account

Close Modal
Close Modal